MYD88 and neoplasm: The ligation of IL‐18 to its receptor activates MyD88 signaling pathway, which resultantly induces IFNγ production.7 In the context of tumor, tumor‐infiltrating lymphocytes (TILs) are the main source of IFNγ, which have shown of particular importance in tumor immunosurveillance.